UniProt ID | M3K8_HUMAN | |
---|---|---|
UniProt AC | P41279 | |
Protein Name | Mitogen-activated protein kinase kinase kinase 8 | |
Gene Name | MAP3K8 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 467 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Required for lipopolysaccharide (LPS)-induced, TLR4-mediated activation of the MAPK/ERK pathway in macrophages, thus being critical for production of the proinflammatory cytokine TNF-alpha (TNF) during immune responses. Involved in the regulation of T-helper cell differentiation and IFNG expression in T-cells. Involved in mediating host resistance to bacterial infection through negative regulation of type I interferon (IFN) production. In vitro, activates MAPK/ERK pathway in response to IL1 in an IRAK1-independent manner, leading to up-regulation of IL8 and CCL4. Transduces CD40 and TNFRSF1A signals that activate ERK in B-cells and macrophages, and thus may play a role in the regulation of immunoglobulin production. May also play a role in the transduction of TNF signals that activate JNK and NF-kappa-B in some cell types. In adipocytes, activates MAPK/ERK pathway in an IKBKB-dependent manner in response to IL1B and TNF, but not insulin, leading to induction of lipolysis. Plays a role in the cell cycle. Isoform 1 shows some transforming activity, although it is much weaker than that of the activated oncogenic variant.. | |
Protein Sequence | MEYMSTGSDNKEEIDLLIKHLNVSDVIDIMENLYASEEPAVYEPSLMTMCQDSNQNDERSKSLLLSGQEVPWLSSVRYGTVEDLLAFANHISNTAKHFYGQRPQESGILLNMVITPQNGRYQIDSDVLLIPWKLTYRNIGSDFIPRGAFGKVYLAQDIKTKKRMACKLIPVDQFKPSDVEIQACFRHENIAELYGAVLWGETVHLFMEAGEGGSVLEKLESCGPMREFEIIWVTKHVLKGLDFLHSKKVIHHDIKPSNIVFMSTKAVLVDFGLSVQMTEDVYFPKDLRGTEIYMSPEVILCRGHSTKADIYSLGATLIHMQTGTPPWVKRYPRSAYPSYLYIIHKQAPPLEDIADDCSPGMRELIEASLERNPNHRPRAADLLKHEALNPPREDQPRCQSLDSALLERKRLLSRKELELPENIADSSCTGSTEESEMLKRQRSLYIDLGALAGYFNLVRGPPTLEYG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MEYMSTGSDNKE ---CCCCCCCCCCHH | 28.81 | 27251275 | |
6 | Phosphorylation | --MEYMSTGSDNKEE --CCCCCCCCCCHHH | 24.95 | 27251275 | |
8 | Phosphorylation | MEYMSTGSDNKEEID CCCCCCCCCCHHHHH | 37.79 | 27251275 | |
62 | Phosphorylation | QNDERSKSLLLSGQE CCCHHHHHHHHCCCC | 26.04 | 16806191 | |
74 | Phosphorylation | GQEVPWLSSVRYGTV CCCCCCCCCCCCCCH | 23.95 | 24719451 | |
80 | Phosphorylation | LSSVRYGTVEDLLAF CCCCCCCCHHHHHHH | 16.28 | 17472361 | |
106 | Phosphorylation | YGQRPQESGILLNMV CCCCCCCCCEEEEEE | 26.36 | 28270605 | |
115 | Phosphorylation | ILLNMVITPQNGRYQ EEEEEEECCCCCEEE | 13.86 | 28270605 | |
121 | Phosphorylation | ITPQNGRYQIDSDVL ECCCCCEEEECCCEE | 15.95 | 28270605 | |
125 | Phosphorylation | NGRYQIDSDVLLIPW CCEEEECCCEEEEEE | 31.11 | 16806191 | |
135 | Phosphorylation | LLIPWKLTYRNIGSD EEEEEECEECCCCCC | 19.39 | 29514088 | |
136 | Phosphorylation | LIPWKLTYRNIGSDF EEEEECEECCCCCCC | 16.46 | - | |
141 | Phosphorylation | LTYRNIGSDFIPRGA CEECCCCCCCCCCCC | 26.08 | 19664994 | |
153 | Phosphorylation | RGAFGKVYLAQDIKT CCCCCCEEEECHHHC | 10.37 | - | |
290 | Phosphorylation | FPKDLRGTEIYMSPE CCCCCCCCEEEECCE | 16.87 | 15466476 | |
295 | Phosphorylation | RGTEIYMSPEVILCR CCCEEEECCEEEEEC | 10.84 | 22210691 | |
334 | Phosphorylation | WVKRYPRSAYPSYLY HHHCCCCCCCCCEEE | 27.87 | 16806191 | |
368 | Phosphorylation | MRELIEASLERNPNH HHHHHHHHHHHCCCC | 20.27 | - | |
400 | Phosphorylation | EDQPRCQSLDSALLE CCCCCHHCHHHHHHH | 37.46 | 17472361 | |
413 | Phosphorylation | LERKRLLSRKELELP HHHHHHHCHHHHCCC | 45.99 | 12138205 | |
426 | Phosphorylation | LPENIADSSCTGSTE CCCCCCCCCCCCCHH | 20.49 | 28348404 | |
427 | Phosphorylation | PENIADSSCTGSTEE CCCCCCCCCCCCHHH | 19.08 | 28348404 | |
429 | Phosphorylation | NIADSSCTGSTEESE CCCCCCCCCCHHHHH | 35.79 | 28348404 | |
431 | Phosphorylation | ADSSCTGSTEESEML CCCCCCCCHHHHHHH | 17.94 | 28348404 | |
432 | Phosphorylation | DSSCTGSTEESEMLK CCCCCCCHHHHHHHH | 45.15 | 28348404 | |
443 | Phosphorylation | EMLKRQRSLYIDLGA HHHHHHHHEEEEHHH | 19.72 | 15466476 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
400 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
400 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
400 | S | Phosphorylation | Kinase | PKB_GROUP | - | PhosphoELM |
413 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of M3K8_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NFKB1_HUMAN | NFKB1 | physical | 9950430 | |
NFKB1_HUMAN | NFKB1 | physical | 14743216 | |
NFKB2_HUMAN | NFKB2 | physical | 14743216 | |
TF65_HUMAN | RELA | physical | 14743216 | |
TNIP2_HUMAN | TNIP2 | physical | 14743216 | |
KSR2_HUMAN | KSR2 | physical | 12975377 | |
IKKA_HUMAN | CHUK | physical | 10072079 | |
MP2K1_HUMAN | MAP2K1 | physical | 8631303 | |
MP2K4_HUMAN | MAP2K4 | physical | 8631303 | |
TRAF2_HUMAN | TRAF2 | physical | 11932422 | |
AKT1_HUMAN | AKT1 | physical | 12138205 | |
TNIP2_HUMAN | TNIP2 | physical | 15169888 | |
NFKB1_HUMAN | NFKB1 | physical | 15169888 | |
TRAF2_HUMAN | TRAF2 | physical | 15670770 | |
TRAF6_HUMAN | TRAF6 | physical | 15670770 | |
TAB2_HUMAN | TAB2 | physical | 15670770 | |
HS90A_HUMAN | HSP90AA1 | physical | 22939624 | |
MP2K1_HUMAN | MAP2K1 | physical | 16291755 | |
NFKB1_HUMAN | NFKB1 | physical | 21988832 | |
STIP1_HUMAN | STIP1 | physical | 21988832 | |
NFKB1_HUMAN | NFKB1 | physical | 25852190 | |
NFKB2_HUMAN | NFKB2 | physical | 25852190 | |
TF65_HUMAN | RELA | physical | 25852190 | |
TNIP2_HUMAN | TNIP2 | physical | 25852190 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-141, AND MASSSPECTROMETRY. |